{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:24:24Z","timestamp":1777479864609,"version":"3.51.4"},"reference-count":84,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2019,11,3]]},"DOI":"10.3233\/cbm-190370","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T07:21:37Z","timestamp":1568791297000},"page":"333-342","source":"Crossref","is-referenced-by-count":8,"title":["Serological landscape of cytokines in cutaneous melanoma"],"prefix":"10.1177","volume":"26","author":[{"given":"Alessia","family":"Paganelli","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy"},{"name":"Department of Medicine and Aging Sciences, University \u201cG. d\u2019Annunzio\u201d Chieti-Pescara, Chieti, Italy"},{"name":"Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Garbarino","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy"},{"name":"Department of Medicine and Aging Sciences, University \u201cG. d\u2019Annunzio\u201d Chieti-Pescara, Chieti, Italy"},{"name":"Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Toto","sequence":"additional","affiliation":[{"name":"Private practice, Chieti, Italy"},{"name":"Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe Di","family":"Martino","sequence":"additional","affiliation":[{"name":"Department of Medicine and Aging Sciences, Section of Hygiene, University \u201cG. d\u2019Annunzio\u201d Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marika","family":"D\u2019Urbano","sequence":"additional","affiliation":[{"name":"Department of Medicine and Aging Sciences, University \u201cG. d\u2019Annunzio\u201d Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Auriemma","sequence":"additional","affiliation":[{"name":"Department of Medicine and Aging Sciences, Section of Dermatology, University \u201cG. d\u2019Annunzio\u201d Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela Di","family":"Giovanni","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University \u201cG. d\u2019Annunzio\u201d Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Panarese","sequence":"additional","affiliation":[{"name":"Department of Medicine and Aging Sciences, Section of Dermatology, University \u201cG. d\u2019Annunzio\u201d Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Staniscia","sequence":"additional","affiliation":[{"name":"Department of Medicine and Aging Sciences, Section of Hygiene, University \u201cG. d\u2019Annunzio\u201d Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Amerio","sequence":"additional","affiliation":[{"name":"Department of Medicine and Aging Sciences, Section of Dermatology, University \u201cG. d\u2019Annunzio\u201d Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Paganelli","sequence":"additional","affiliation":[{"name":"Department of Medicine and Aging Sciences, University \u201cG. d\u2019Annunzio\u201d Chieti-Pescara, Chieti, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-190370_ref1","doi-asserted-by":"crossref","unstructured":"M.K. Tripp, M. Watson, S.J. Balk, S.M. Swetter and J.E. Gershenwald, State of the science on prevention and screening to reduce melanoma incidence and mortality: the time is now, CA. Cancer J. Clin. (May 2016).","DOI":"10.3322\/caac.21352"},{"key":"10.3233\/CBM-190370_ref2","first-page":"356","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur. J. Cancer Oxf. Engl. 1990"},{"issue":"6","key":"10.3233\/CBM-190370_ref3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA. Cancer J. Clin."},{"issue":"2","key":"10.3233\/CBM-190370_ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5826\/dpc.0702a01","article-title":"Epidemiological trends in skin cancer","volume":"7","author":"Apalla","year":"2017","journal-title":"Dermatol. Pract. Concept."},{"issue":"6","key":"10.3233\/CBM-190370_ref5","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.mcna.2015.06.002","article-title":"Skin cancer epidemiology, detection, and management","volume":"99","author":"Gandhi","year":"2015","journal-title":"Med. Clin. North Am."},{"issue":"10","key":"10.3233\/CBM-190370_ref6","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1002\/ijc.25576","article-title":"Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma","volume":"128","author":"Cust","year":"2011","journal-title":"Int. J. Cancer J. Int. Cancer"},{"issue":"11","key":"10.3233\/CBM-190370_ref7","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamadermatol.2017.2291","article-title":"Risk factors for melanoma in renal transplant recipients","volume":"153","author":"Ascha","year":"2017","journal-title":"JAMA Dermatol."},{"issue":"3","key":"10.3233\/CBM-190370_ref8","doi-asserted-by":"crossref","first-page":"E269","DOI":"10.1002\/ijc.27357","article-title":"MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family study","volume":"131","author":"Cust","year":"2012","journal-title":"Int. J. Cancer J. Int. Cancer"},{"key":"10.3233\/CBM-190370_ref9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.14694\/EDBK_174930","article-title":"Operable melanoma: screening, prognostication, and adjuvant and neoadjuvant therapy","volume":"37","author":"Tarhini","year":"2017","journal-title":"Am. Soc. Clin. Oncol. Educ. Book Am. Soc. Clin. Oncol. Annu. Meet."},{"issue":"1","key":"10.3233\/CBM-190370_ref10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bjd.12687","article-title":"Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review","volume":"170","author":"Fong","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.3233\/CBM-190370_ref11","unstructured":"et al.Guidelines of care for the management of primary cutaneous melanoma, J. Am. Acad. Dermatol.(Oct. 2018)."},{"key":"10.3233\/CBM-190370_ref12","doi-asserted-by":"crossref","unstructured":"G. Brancaccio et al., Eighth American Joint Committee on Cancer (AJCC) melanoma classification: what about stage IIC? Br. J. Dermatol. (Oct. 2018).","DOI":"10.1111\/bjd.17145"},{"issue":"5","key":"10.3233\/CBM-190370_ref13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2217\/fon-2017-0500","article-title":"Evaluation of the eighth American Joint Committee on Cancer staging system for malignant melanoma of the skin","volume":"14","author":"Abdel-Rahman","year":"2018","journal-title":"Future Oncol."},{"key":"10.3233\/CBM-190370_ref14","doi-asserted-by":"crossref","unstructured":"G.M. Boland and J.E. Gershenwald, Principles of Melanoma Staging, in Melanoma, H.L. Kaufman and J.M. Mehnert, Eds. Cham: Springer International Publishing, Vol. 167, 2016, pp. 131\u2013148.","DOI":"10.1007\/978-3-319-22539-5_5"},{"issue":"6","key":"10.3233\/CBM-190370_ref15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the american joint committee on cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA. Cancer J. Clin."},{"issue":"4","key":"10.3233\/CBM-190370_ref16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/107327480501200403","article-title":"Cutaneous melanoma: prognostic factors","volume":"12","author":"Homsi","year":"2005","journal-title":"Cancer Control J. Moffitt Cancer Cent."},{"issue":"7","key":"10.3233\/CBM-190370_ref17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma","volume":"77","author":"Clemente","year":"1996","journal-title":"Cancer"},{"issue":"6","key":"10.3233\/CBM-190370_ref18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1586\/14737159.2014.928206","article-title":"Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment","volume":"14","author":"Camisaschi","year":"2014","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"6","key":"10.3233\/CBM-190370_ref19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/14712598.2017.1309387","article-title":"Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy","volume":"17","author":"Zito Marino","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.3233\/CBM-190370_ref20","doi-asserted-by":"crossref","unstructured":"R. Samaniego et al., CCL20 expression by tumor-associated macrophages predicts progression of human primary cutaneous melanoma, Cancer Immunol. Res. (Jan. 2018).","DOI":"10.1158\/2326-6066.CIR-17-0198"},{"issue":"10","key":"10.3233\/CBM-190370_ref21","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00262-016-1881-y","article-title":"Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases","volume":"65","author":"Mauldin","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.3233\/CBM-190370_ref22","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1172\/JCI66236","article-title":"Host immunity contributes to the anti-melanoma activity of BRAF inhibitors","volume":"123","author":"Knight","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.3233\/CBM-190370_ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/9212134","article-title":"Inflammatory cytokine pattern is sex-dependent in mouse cutaneous melanoma experimental model","volume":"2017","author":"Surcel","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.3233\/CBM-190370_ref24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/15384047.2018.1435223","article-title":"A vaccine targeting basic fibroblast growth factor elicits a protective immune response against murine melanoma","volume":"19","author":"Zhang","year":"2018","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.3233\/CBM-190370_ref25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.stem.2018.01.016","article-title":"Autologous iPSC-based vaccines elicit anti-tumor responses in vivo","volume":"22","author":"Kooreman","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.3233\/CBM-190370_ref26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1023\/A:1008307821189","article-title":"Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes","volume":"10","author":"Maraveyas","year":"1999","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"issue":"2","key":"10.3233\/CBM-190370_ref27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1067\/S0190-9622(03)00921-6","article-title":"Immunologic escape and angiogenesis in human malignant melanoma","volume":"49","author":"Redondo","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.3233\/CBM-190370_ref28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00008390-200010010-00008","article-title":"Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients","volume":"10","author":"Bernengo","year":"2000","journal-title":"Melanoma Res."},{"key":"10.3233\/CBM-190370_ref29","first-page":"S81","article-title":"Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape","volume":"6","author":"Rayman","year":"2000","journal-title":"Cancer J. Sci. Am."},{"issue":"5","key":"10.3233\/CBM-190370_ref30","first-page":"394","article-title":"Lymphocyte counts independently predict overall survival in advanced cancer patients: a biomarker for IL-2 immunotherapy","volume":"26","author":"Fumagalli","year":"2003","journal-title":"J. Immunother. Hagerstown Md 1997"},{"key":"10.3233\/CBM-190370_ref31","doi-asserted-by":"crossref","unstructured":"S. Izraely et al., The metastatic microenvironment: melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells, Int. J. Cancer (Jul. 2018).","DOI":"10.1002\/ijc.31745"},{"issue":"1","key":"10.3233\/CBM-190370_ref32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/path.4509","article-title":"Astrocytes facilitate melanoma brain metastasis via secretion of IL-23: astrocytes facilitate melanoma brain metastasis via IL-23","volume":"236","author":"Klein","year":"2015","journal-title":"J. Pathol."},{"key":"10.3233\/CBM-190370_ref33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cytogfr.2017.07.002","article-title":"Immunotherapy targeting immune check-point(s) in brain metastases","volume":"36","author":"Di Giacomo","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"issue":"S11","key":"10.3233\/CBM-190370_ref34","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/cncr.30594","article-title":"Molecular insights into melanoma brain metastases: insights into melanoma brain metastases","volume":"123","author":"Westphal","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.3233\/CBM-190370_ref35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00417-016-3541-5","article-title":"Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors","volume":"255","author":"Usui","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol."},{"issue":"3","key":"10.3233\/CBM-190370_ref36","first-page":"604","article-title":"Immunotherapy in melanoma: recent advances and future directions","volume":"43","author":"Franklin","year":"2017","journal-title":"Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"key":"10.3233\/CBM-190370_ref37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.clim.2016.07.006","article-title":"Metastatic melanoma and immunotherapy","volume":"172","author":"Herzberg","year":"2016","journal-title":"Clin. Immunol. Orlando Fla"},{"issue":"6","key":"10.3233\/CBM-190370_ref38","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4161\/cbt.28555","article-title":"Melanoma immunotherapy","volume":"15","author":"Sanlorenzo","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.3233\/CBM-190370_ref39","doi-asserted-by":"crossref","unstructured":"H. Cirenajwis et al., Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy, Oncotarget 6(14) (May 2015).","DOI":"10.18632\/oncotarget.3655"},{"issue":"23","key":"10.3233\/CBM-190370_ref40","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1158\/0008-5472.CAN-15-2303","article-title":"Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab","volume":"75","author":"Koguchi","year":"2015","journal-title":"Cancer Res."},{"key":"10.3233\/CBM-190370_ref41","first-page":"1","article-title":"Combination immunotherapies implementing adoptive T-cell transfer for advanced-stage melanoma","author":"Foley","year":"2018","journal-title":"Melanoma Res."},{"issue":"7","key":"10.3233\/CBM-190370_ref42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10585-007-9093-7","article-title":"Serum angiogenin levels predict treatment response in patients with stage IV melanoma","volume":"24","author":"Vihinen","year":"2007","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"10.3233\/CBM-190370_ref43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2217\/17520363.3.1.71","article-title":"Biomarkers of metastatic melanoma","volume":"3","author":"Neagu","year":"2009","journal-title":"Biomark. Med."},{"issue":"12","key":"10.3233\/CBM-190370_ref44","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2014.58.0209","article-title":"C-reactive protein as a marker of melanoma progression","volume":"33","author":"Fang","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.3233\/CBM-190370_ref45","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/cas.13226","article-title":"Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma","volume":"108","author":"Yamazaki","year":"2017","journal-title":"Cancer Sci."},{"issue":"7","key":"10.3233\/CBM-190370_ref46","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1054\/bjoc.2000.1402","article-title":"Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma","volume":"83","author":"Boyano","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.3233\/CBM-190370_ref47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00008390-200108000-00010","article-title":"Serum imbalance of cytokines in melanoma patients","volume":"11","author":"Moretti","year":"2001","journal-title":"Melanoma Res."},{"issue":"7","key":"10.3233\/CBM-190370_ref48","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1586\/erm.10.81","article-title":"Immune-related biomarkers for diagnosis\/prognosis and therapy monitoring of cutaneous melanoma","volume":"10","author":"Neagu","year":"2010","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"10","key":"10.3233\/CBM-190370_ref49","first-page":"3895","article-title":"Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy","volume":"6","author":"Grimm","year":"2000","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"7","key":"10.3233\/CBM-190370_ref50","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/0973-1482.145816","article-title":"Identification of melanoma biomarkers based on network modules by integrating the human signaling network with microarrays","volume":"10","author":"Chen","year":"2014","journal-title":"J. Cancer Res. Ther."},{"issue":"15","key":"10.3233\/CBM-190370_ref51","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1158\/1078-0432.CCR-12-0343","article-title":"Molecular profiling reveals low- and high-grade forms of primary melanoma","volume":"18","author":"Harbst","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.3233\/CBM-190370_ref52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/bjd.12493","article-title":"Molecular markers in melanoma","volume":"170","author":"Kashani-Sabet","year":"2014","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.3233\/CBM-190370_ref53","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/CJI.0b013e3181fb045d","article-title":"Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma","volume":"33","author":"Dengel","year":"2010","journal-title":"J. Immunother."},{"issue":"5","key":"10.3233\/CBM-190370_ref54","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ijc.2910560524","article-title":"Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma","volume":"56","author":"Chen","year":"1994","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.3233\/CBM-190370_ref55","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1081\/CNV-100102550","article-title":"Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma","volume":"19","author":"Nemunaitis","year":"2001","journal-title":"Cancer Invest."},{"issue":"4","key":"10.3233\/CBM-190370_ref56","first-page":"1105","article-title":"Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis","volume":"151","author":"Luca","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.3233\/CBM-190370_ref57","first-page":"3537","article-title":"Evaluation of IL-2, IL-6, IL-8 and IL-10 in malignant melanoma diagnostics","volume":"35","author":"Kucera","year":"2015","journal-title":"Anticancer Res."},{"issue":"5","key":"10.3233\/CBM-190370_ref58","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00262-011-0982-x","article-title":"Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction","volume":"60","author":"Lee","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.3233\/CBM-190370_ref59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/B978-0-12-394383-5.00011-4","article-title":"The immune system \u2013 a hidden treasure for biomarker discovery in cutaneous melanoma","volume":"58","author":"Neagu","year":"2012","journal-title":"Adv. Clin. Chem."},{"issue":"6","key":"10.3233\/CBM-190370_ref60","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/15321819.2015.1035593","article-title":"Chemokines in the melanoma metastasis biomarkers portrait","volume":"36","author":"Neagu","year":"2015","journal-title":"J. Immunoassay Immunochem."},{"issue":"3","key":"10.3233\/CBM-190370_ref61","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.metabol.2014.10.027","article-title":"Biomarkers for personalized oncology: recent advances and future challenges","volume":"64","author":"Kalia","year":"2015","journal-title":"Metabolism"},{"issue":"8","key":"10.3233\/CBM-190370_ref62","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1158\/1078-0432.CCR-06-1805","article-title":"Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b","volume":"13","author":"Yurkovetsky","year":"2007","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.3233\/CBM-190370_ref63","doi-asserted-by":"crossref","unstructured":"R. Jamal et al., Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin\/paclitaxel in unresectable stage III or stage IV melanoma, J. Immunother. Cancer 5(1) (Dec. 2017).","DOI":"10.1186\/s40425-017-0290-x"},{"issue":"8","key":"10.3233\/CBM-190370_ref64","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/annonc\/mdx190","article-title":"Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients","volume":"28","author":"Sanmamed","year":"2017","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.3233\/CBM-190370_ref65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/107940","article-title":"Immune parameters in the prognosis and therapy monitoring of cutaneous melanoma patients: experience, role, and limitations","volume":"2013","author":"Neagu","year":"2013","journal-title":"BioMed Res. Int."},{"issue":"5","key":"10.3233\/CBM-190370_ref66","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/(SICI)1097-0215(19960529)66:5<607::AID-IJC4>3.0.CO;2-X","article-title":"Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions","volume":"66","author":"Dummer","year":"1996","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.3233\/CBM-190370_ref67","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/exd.12629","article-title":"Role of IL-10 and TGF-\u03b2 in melanoma","volume":"24","author":"Wiguna","year":"2015","journal-title":"Exp. Dermatol."},{"issue":"8","key":"10.3233\/CBM-190370_ref68","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/CJI.0b013e318158795b","article-title":"Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients","volume":"30","author":"Torisu-Itakura","year":"2007","journal-title":"J. Immunother."},{"issue":"6","key":"10.3233\/CBM-190370_ref69","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0002-9440(10)63238-5","article-title":"Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions","volume":"165","author":"Gerlini","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.3233\/CBM-190370_ref70","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s12253-015-9938-3","article-title":"Decreased interferon \u03b3 production in CD3+ and CD3-CD56+ lymphocyte subsets in metastatic regional lymph nodes of melanoma patients","volume":"21","author":"Vuleti\u0107","year":"2015","journal-title":"Pathol. Oncol. Res."},{"issue":"1","key":"10.3233\/CBM-190370_ref71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1478-811X-10-41","article-title":"Interferon-\u03b3-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells","volume":"10","author":"Schmitt","year":"2012","journal-title":"Cell Commun. Signal."},{"issue":"9","key":"10.3233\/CBM-190370_ref72","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1158\/1078-0432.CCR-10-2114","article-title":"Association of IFN-signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines","volume":"17","author":"Respa","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.3233\/CBM-190370_ref73","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/jir.1996.16.577","article-title":"Interferon-\u03b2 prevents the upregulation of interleukin-8 expression in human melanoma cells","volume":"16","author":"Singh","year":"1996","journal-title":"J. Interferon Cytokine Res."},{"issue":"10","key":"10.3233\/CBM-190370_ref74","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.biocel.2003.10.019","article-title":"Macrophage inflammatory protein-1","volume":"36","author":"Maurer","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.3233\/CBM-190370_ref75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2007.02.012","article-title":"Dichotomous effects of C-C chemokines in HIV-1 pathogenesis","volume":"110","author":"Ansari","year":"2007","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.3233\/CBM-190370_ref76","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ajpath.2011.09.005","article-title":"Host-derived MCP-1 and MIP-1\u03b1 regulate protective anti-tumor immunity to localized and metastatic B16 melanoma","volume":"180","author":"Nakasone","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.3233\/CBM-190370_ref77","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/1744666X.2017.1384313","article-title":"Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3","volume":"13","author":"Schaller","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"7","key":"10.3233\/CBM-190370_ref78","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neo.2017.02.014","article-title":"Activated natural killer cells mediate the suppressive effect of interleukin-4 on tumor development via STAT6 activation in an atopic condition melanoma model","volume":"19","author":"Son","year":"2017","journal-title":"Neoplasia N. Y. N"},{"issue":"3","key":"10.3233\/CBM-190370_ref79","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3390\/ijms12031505","article-title":"IL8 and cathepsin B as melanoma serum biomarkers","volume":"12","author":"Zhang","year":"2011","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.3233\/CBM-190370_ref80","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.yexcr.2006.10.030","article-title":"Regulation of interleukin-8 expression in melanoma-stimulated neutrophil inflammatory response","volume":"313","author":"Peng","year":"2007","journal-title":"Exp. Cell Res."},{"key":"10.3233\/CBM-190370_ref81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/904876","article-title":"25-OH vitamin D and interleukin-8: emerging biomarkers in cutaneous melanoma development and progression","volume":"2015","author":"Ene","year":"2015","journal-title":"Mediators Inflamm."},{"issue":"10","key":"10.3233\/CBM-190370_ref82","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.oraloncology.2011.07.034","article-title":"Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer","volume":"47","author":"Argiris","year":"2011","journal-title":"Oral Oncol."},{"issue":"5","key":"10.3233\/CBM-190370_ref83","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/bjd.14727","article-title":"An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel","volume":"175","author":"Thurneysen","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.3233\/CBM-190370_ref84","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20160855","article-title":"An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition","volume":"214","author":"Young","year":"2017","journal-title":"J. Exp. Med."}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-190370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:07:13Z","timestamp":1777385233000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-190370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,3]]},"references-count":84,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/cbm-190370","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,3]]}}}